Companies / Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc.

Nasdaq: BDTXCIK 1701541CAMBRIDGE, MA

Financials · FY2020

Revenue$0
Net income$22.37M
Total debt—
Cash$19.19M
Diluted EPS$0.39
Shares outstanding57.5M

Ownership

57.5M shares outstanding · as of Jul 30, 2026
0.23%Insiders
Ownership
Insiders0.23%130,700
Institutions73.30%42,113,502
Public float26.47%15,209,545

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 7

View all →
Insider% of sharesShares
Behbahani AliDirector
0.16%93,568
Raman PrakashDirector
0.06%37,132
Buck ElizabethCHIEF SCIENTIFIC OFFICER
——
Hatzis-Schoch BrentSEE REMARKS
——
Jones ErikaSEE REMARKS
——
Velleca Mark A.CEOPRESIDENT & CEO · Director
——
Yurasov SergeyCHIEF MEDICAL OFFICER
——

Institutional holders 110

View all →
HolderValue% of shares
NEA Management Company, LLC$10.81M7.74%
BlackRock, Inc.$7.25M6.82%
Vanguard Group Inc$5.32M3.81%
Renaissance Technologies LLC$3.50M2.86%
Siren, L.L.C.$2.54M1.82%
Jane Street Group, LLC$2.34M1.67%
Vestal Point Capital, LP$2.11M1.51%
Dimensional Fund Advisors LP$2.08M1.49%
Marshall Wace, LLP$1.78M1.46%
Arrowstreet Capital, Limited Partnership$1.78M1.45%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 20, 2026Behbahani Ali
Director
GrantCommon Stock$14.9K+7K
+7.99%
93,568
0.16% of shares
low
Mar 20, 2026Raman Prakash
Director
GrantCommon Stock$13.1K+6K
+19.68%
37,132
0.06% of shares
low
Jan 21, 2026Velleca Mark A.
CEO
GrantStock Option (Right to Buy)—+600K
600,000
1.04% of shares
low
Jan 21, 2026Jones Erika
Executive
GrantStock Option (Right to Buy)—+200K
200,000
0.35% of shares
low
Jan 21, 2026Buck Elizabeth
Executive
GrantStock Option (Right to Buy)—+250K
250,000
0.44% of shares
low
Jan 21, 2026Yurasov Sergey
Executive
GrantStock Option (Right to Buy)—+250K
250,000
0.44% of shares
low
Jan 21, 2026Hatzis-Schoch Brent
Executive
GrantStock Option (Right to Buy)—+250K
250,000
0.44% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vestal Point Capital, LPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
BDTXCommon StockEquity09203E105BBG00MS4Y0W9